[{"AccountsPayableCurrent_0_Q1_USD":8998000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":38000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":86000.0,"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_1_Q1_USD":64000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1829000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q1_USD":48000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":110000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":4000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1223000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1829000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":54328000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-379000.0,"PrepaidInsurance_0_Q1_USD":1693000.0,"OtherPrepaidExpenseCurrent_0_Q1_USD":407000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":48000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":338000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-19142000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q1_USD":3057000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q1_USD":9809000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q1_USD":7134000.0,"InvestmentIncomeInterest_1_Q1_USD":333000.0,"ShortTermInvestments_0_Q1_USD":54376000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":7795000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":54376000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":20020000.0,"Supplies_0_Q1_USD":152000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":379000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q1_USD":115000.0,"ProceedsFromStockPlans_1_Q1_USD":64000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":15885000.0,"ProceedsFromDebtNetOfIssuanceCosts_1_Q1_USD":19730000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":34938000.0,"PaidInKindInterest_1_Q1_USD":62000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":608000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":44744000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":306000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"LongTermLoansPayable_0_Q1_USD":19792000.0,"InterestReceivableCurrent_0_Q1_USD":167000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-2512000.0,"DepositsAssetsCurrent_0_Q1_USD":2343000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":0.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":82000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":12754000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":1517000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":480000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-15188000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":564164000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":535000.0,"ProfitLoss_1_Q1_USD":-15236000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5086000.0,"NetIncomeLoss_1_Q1_USD":-15236000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-15925000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-19053000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":54998000.0,"LiabilitiesNoncurrent_0_Q1_USD":32856000.0,"LiabilitiesCurrent_0_Q1_USD":18790000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":105155000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":259000.0,"Liabilities_0_Q1_USD":51646000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":2820000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5917000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.56,"CommonStockValue_0_Q1_USD":3000.0,"CommonStockSharesOutstanding_0_Q1_shares":30240838.0,"CommonStockSharesIssued_0_Q1_shares":30240838.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":44629000.0,"AssetsCurrent_0_Q1_USD":104206000.0,"Assets_0_Q1_USD":105155000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2530000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-510706000.0,"StockholdersEquity_0_Q1_USD":53509000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":34328640.0,"OtherAssetsNoncurrent_0_Q1_USD":82000.0,"NonoperatingIncomeExpense_1_Q1_USD":-136000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-20000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":373000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":338000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":51034.0,"StockIssuedDuringPeriodSharesNewIssues_0_Q1_shares":2095039.0,"ShareBasedCompensation_1_Q1_USD":1829000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":9562000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-15100000.0,"OperatingExpenses_1_Q1_USD":15479000.0,"InterestPaidNet_1_Q1_USD":126000.0,"InterestExpense_1_Q1_USD":449000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":20000000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"UnamortizedDebtIssuanceExpense_0_Q1_USD":257000.0,"UnamortizedLossReacquiredDebtNoncurrent_0_Q1_USD":49000.0,"Ticker":"SNDX","CIK":"1395937","name":"SYNDAX PHARMACEUTICALS INC","OfficialName":"Syndax Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"934158860.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]